← Open Payments lookup

EVELYN RAMOS: Open Payments

NPI 1033679006 · ADELPHI, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,174 in 45 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $508 · 2025 $1,174

Food & beverage: $1,075Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.24$643
Madrigal Pharmaceuticals8$209
Ardelyx, Inc.3$93
ABBVIE INC.2$55
PFIZER INC.2$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$41
Takeda Pharmaceuticals U.S.A., Inc.2$36
GENZYME CORPORATION1$25
Novo Nordisk Inc1$22

Products named: TREMFYA, REZDIFFRA, IBSRELA, LINZESS, XELJANZ, XIFAXAN, DUPIXENT, Wegovy.

Industry payments across MD — which companies pay providers there.